Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 6 stocks made the list for top value stocks in the Health Care Providers & Services industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.
Why Focus on Undervalued Health Care Providers & Services Stocks?
Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.
AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
What Goes Into AAII’s Value Grade?
Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.
Click the button below to learn more about A+ Investor and subscribe today.
6 Undervalued Health Care Providers & Services Stocks
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Health Care Providers & Services industry for Friday, February 20, 2026. Let’s take a closer look at their individual scores to see how they measure up against each other and the Health Care Providers & Services industry median.
| Company | Ticker | Price/Sales | Price/Earnings | EV/EBITDA | Shareholder Yield | Price/Book Value | Price/Free Cash Flow | Value Grade |
| AdaptHealth Corp. | AHCO | 0.42 | 18.3 | 11.3 | (0.8%) | 0.82 | 6.4 | A |
| Cardinal Health, Inc. | CAH | 0.22 | 32.1 | 13.9 | 3.4% | na | 10.6 | B |
| CVS Health Corporation | CVS | 0.24 | 55.6 | 10.2 | 2.5% | 1.31 | 22.2 | B |
| Enhabit, Inc. | EHAB | 0.54 | na | 10.6 | (1.0%) | 0.99 | 9.8 | B |
| HCA Healthcare, Inc. | HCA | 1.70 | 18.7 | 9.4 | 10.2% | na | 17.8 | B |
| Molina Healthcare, Inc. | MOH | 0.18 | 16.6 | 10.9 | 10.1% | 1.86 | na | A |
The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.
The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)
Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).
As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.
AdaptHealth Corp.’s Value Grade
Value Grade:
| Metric | Score | AHCO | Industry Median |
| Price/Sales | 17 | 0.42 | 1.01 |
| Price/Earnings | 44 | 18.3 | 22.4 |
| EV/EBITDA | 42 | 11.3 | 13.4 |
| Shareholder Yield | 55 | (0.8%) | (1.1%) |
| Price/Book Value | 18 | 0.82 | 2.34 |
| Price/Free Cash Flow | 14 | 6.4 | 20.7 |
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
AdaptHealth Corp. has a Value Score of 81, which is considered to be undervalued.
When you look at AdaptHealth Corp.’s price-to-sales ratio at 0.42 compared to the industry median at 1.01, this company has a lower price relative to revenue compared to its peers. This could make AdaptHealth Corp.’s stock more attractive for value investors.
AdaptHealth Corp.’s price-earnings ratio is 18.30 compared to the industry median at 22.40. This means it has a lower share price relative to earnings compared to its peers. This could make AdaptHealth Corp. more attractive for value investors.
Now, let’s assess AdaptHealth Corp.’s EV/EBITDA ratio, also known as enterprise multiple. At 11.3, when compared to the industry median of 13.4, the company may be considered undervalued in relation to its peers. Value investors could use the enterprise multiple to identify stocks that are considered overvalued or undervalued relative to their industry.
Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. AdaptHealth Corp.’s shareholder yield is higher than its industry median ratio of (1.10%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.
As one of the most common value metrics, the price-to-book ratio evaluates a company’s current market price relative to its book value. AdaptHealth Corp.’s price-to-book ratio is lower than its industry median ratio of 2.34. This could make AdaptHealth Corp. more attractive to investors looking for a new addition to their portfolio.
Lastly, let’s take a look at AdaptHealth Corp.’s price-to-free-cash-flow ratio (P/FCF), which can indicate a company’s market value relative to its operating cash flow. AdaptHealth Corp.’s price-to-free-cash-flow ratio is lower than its industry median ratio of 20.70. This could make AdaptHealth Corp. more attractive because the lower P/FCF ratio indicates that AdaptHealth Corp. is undervalued. The P/FCF ratio metric can also be viewed over a long-term time frame to see if the company's cash flow to share price value is generally improving or worsening.
Cardinal Health, Inc.’s Value Grade
Value Grade:
| Metric | Score | CAH | Industry Median |
| Price/Sales | 10 | 0.22 | 1.01 |
| Price/Earnings | 71 | 32.1 | 22.4 |
| EV/EBITDA | 55 | 13.9 | 13.4 |
| Shareholder Yield | 22 | 3.4% | (1.1%) |
| Price/Book Value | na | na | 2.34 |
| Price/Free Cash Flow | 25 | 10.6 | 20.7 |
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Cardinal Health, Inc. has a Value Score of 71, which is considered to be undervalued.
Cardinal Health, Inc.’s price-earnings ratio is 32.1 compared to the industry median at 22.4. This means that it has a higher price relative to its earnings compared to its peers. This makes Cardinal Health, Inc. less attractive for value investors.
You can read more about Cardinal Health, Inc.’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
CVS Health Corporation’s Value Grade
Value Grade:
| Metric | Score | CVS | Industry Median |
| Price/Sales | 10 | 0.24 | 1.01 |
| Price/Earnings | 86 | 55.6 | 22.4 |
| EV/EBITDA | 36 | 10.2 | 13.4 |
| Shareholder Yield | 28 | 2.5% | (1.1%) |
| Price/Book Value | 35 | 1.31 | 2.34 |
| Price/Free Cash Flow | 55 | 22.2 | 20.7 |
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
CVS Health Corporation has a Value Score of 61, which is considered to be undervalued.
CVS Health Corporation’s price-earnings ratio is 55.6 compared to the industry median at 22.4. This means that it has a higher price relative to its earnings compared to its peers. This makes CVS Health Corporation less attractive for value investors.
CVS Health Corporation’s price-to-book ratio is higher than its peers. This could make CVS Health Corporation less attractive for value investors when compared to the industry median at 2.34.
You can read more about CVS Health Corporation’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Enhabit, Inc.’s Value Grade
Value Grade:
| Metric | Score | EHAB | Industry Median |
| Price/Sales | 20 | 0.54 | 1.01 |
| Price/Earnings | na | na | 22.4 |
| EV/EBITDA | 38 | 10.6 | 13.4 |
| Shareholder Yield | 56 | (1.0%) | (1.1%) |
| Price/Book Value | 23 | 0.99 | 2.34 |
| Price/Free Cash Flow | 23 | 9.8 | 20.7 |
Enhabit, Inc. provides home health and hospice services in the United States. The company’s home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Enhabit, Inc. has a Value Score of 80, which is considered to be undervalued.
Enhabit, Inc.’s price-to-book ratio is higher than its peers. This could make Enhabit, Inc. less attractive for value investors when compared to the industry median at 2.34.
You can read more about Enhabit, Inc.’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
HCA Healthcare, Inc.’s Value Grade
Value Grade:
| Metric | Score | HCA | Industry Median |
| Price/Sales | 45 | 1.70 | 1.01 |
| Price/Earnings | 45 | 18.7 | 22.4 |
| EV/EBITDA | 31 | 9.4 | 13.4 |
| Shareholder Yield | 4 | 10.2% | (1.1%) |
| Price/Book Value | na | na | 2.34 |
| Price/Free Cash Flow | 45 | 17.8 | 20.7 |
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
HCA Healthcare, Inc. has a Value Score of 77, which is considered to be undervalued.
HCA Healthcare, Inc.’s price-earnings ratio is 18.7 compared to the industry median at 22.4. This means that it has a lower price relative to its earnings compared to its peers. This makes HCA Healthcare, Inc. more attractive for value investors.
You can read more about HCA Healthcare, Inc.’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Molina Healthcare, Inc.’s Value Grade
Value Grade:
| Metric | Score | MOH | Industry Median |
| Price/Sales | 8 | 0.18 | 1.01 |
| Price/Earnings | 39 | 16.6 | 22.4 |
| EV/EBITDA | 40 | 10.9 | 13.4 |
| Shareholder Yield | 5 | 10.1% | (1.1%) |
| Price/Book Value | 49 | 1.86 | 2.34 |
| Price/Free Cash Flow | na | na | 20.7 |
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Molina Healthcare, Inc. has a Value Score of 86, which is considered to be undervalued.
Molina Healthcare, Inc.’s price-earnings ratio is 16.6 compared to the industry median at 22.4. This means that it has a lower price relative to its earnings compared to its peers. This makes Molina Healthcare, Inc. more attractive for value investors.
Molina Healthcare, Inc.’s price-to-book ratio is higher than its peers. This could make Molina Healthcare, Inc. less attractive for value investors when compared to the industry median at 2.34.
You can read more about Molina Healthcare, Inc.’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Other Health Care Providers & Services Stock Grades
Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.
Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Health Care Providers & Services stocks as well as other industrys.
Choosing Which of the 6 Best Health Care Providers & Services Stocks Is Right for You
Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.
- AdaptHealth Corp. stock has a Value Grade of A.
- Cardinal Health, Inc. stock has a Value Grade of B.
- CVS Health Corporation stock has a Value Grade of B.
- Enhabit, Inc. stock has a Value Grade of B.
- HCA Healthcare, Inc. stock has a Value Grade of B.
- Molina Healthcare, Inc. stock has a Value Grade of A.
Now that you have a bit more background about each of the 6 undervalued stocks in the Health Care Providers & Services industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.
We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.
A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
Additional Resources About Health Care Providers & Services Stocks
Want to learn more about Health Care Providers & Services stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.
- 6 Undervalued Health Care Providers & Services Stocks for Friday, February 20
- Is HCA Healthcare, Inc.
(HCA) Overvalued? - Is UnitedHealth Group Incorporated (UNH) Overvalued?
- 7 Undervalued Health Care Providers & Services Stocks for Thursday, February 19
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.